Introduction {#sec1-1}
============

Chronic obstructive pulmonary disease (COPD) is a common respiratory condition characterized by limitation in airflow. It affects more than 5% of the population and is associated with high morbidity and mortality.\[[@ref1]\] It is characterized by increased frequency and severity of coughing, worsening chest discomfort, wheezing, cough, and sputum productions.\[[@ref2]\] Most of the exacerbations are due to respiratory infections, some are due to environmental pollution, while a small fraction of cases etiology remains unknown.\[[@ref3]\] Symptomatic hypocalcemia (of any etiology) is one of those rare causes of acute exacerbation where the cause may remain obscured during the presentation. The typical presentations of symptomatic hypocalcemia are paresthesias (perioral and extremities), muscle spasms, seizures, cardiac arrhythmias, Chvostek sign, Trousseau\'s sign, tetany (clinical or latent), and rarely bronchospasm\[[@ref4]\] Here, we are reporting a case of severe hypocalcemia induced bronchospasm, presenting as acute exacerbation in a diagnosed case of COPD.

Case Report {#sec1-2}
===========

61 years old female patient, homemaker by occupation and from a rural background and low socio-economic status with a past history of chronic exposure to household wood smoke has presented to us with acute onset shortness of breath for 3 days and paresthesia around the cheek, lips, and bilateral upper limbs. There was no history of fever, chest pain, hemoptysis, altered sensorium abdominal pain, frequent fracture, any exposure to environmental pollutants. She is a known case of COPD for 1 year and was on the metered-dose inhaler (beta agonist + steroid). No past history of any head and neck surgery or renal stone. On admission, she was tachypneic and bilateral rhonchi on auscultation. She was nebulized with Budecort and salbutamol. The injectable steroid was given. But symptoms didn\'t improve satisfactorily. Her arterial blood gas (ABG) analysis showed low ionized calcium and her ECG \[[Figure 1](#F1){ref-type="fig"}\] showed prolong QTc interval. Her blood chemistry reveals hypocalcemia. She was given injection calcium gluconate (10%) 10 mL IV bolus over 10 min and then put on calcium gluconate infusion (11 amp, i.e. approx. 1000 mg elemental) in 1 L of 5% dextrose for next 24 h and admitted in a medical intensive unit. Apparently, clear chest X-ray \[[Figure 2](#F2){ref-type="fig"}\] and normal procalcitonin ruled out the infective etiology as a precipitating factor. Further evaluation revealed low serum magnesium and parathyroid hormone (PTH) levels along with normal vitamin D levels. Subsequently, she was given magnesium correction and put on oral calcitriol and calcium supplement along with inhalational beta-agonist. Gradually her symptoms improved. These are her laboratory investigation report \[[Table 1](#T1){ref-type="table"}\].

![Chest x ray showing hyperinflation and no evidence of any infective etiology](JFMPC-9-2541-g001){#F1}

![ECG showing prolong QTc (520msec) due to hypocalcaemia](JFMPC-9-2541-g002){#F2}

###### 

Laboratory investigation reports of the patient

  Investigation                                 Date      Date   Date
  ------------------------- ------------------- --------- ------ ------
  Hb%                       12-15               10.4             
  TLC (/mm^3^)              4000-10000          7400             
  Platelet (/mm^3^)         1.5-4.5 lakh        2.4lakh          
  Bilirubin (T) (mg/dL)     0.2-1.10            0.54             
  Bilirubin (D) (mg/dL)     \<0.20              0.17             
  SGPT (U/L)                0-45                48               
  SGOT (U/L)                0-40                51               
  ALP (U/L)                 Up to 270           94               
  GGT (U/L)                 5-36                32               
  S. protein (gm/dL)        6.40-8.10           8.4              
  S. albumin (gm/dL)        3.2-4.6             4.0              
  S. globulin (gm/dL)       3.20-4.60           4.4              
  Blood urea (mg/dL)        17-50               35               
  S. creatinine (mg/dL)     0.5-1.20            0.40             
  S. Na+ (mEq/L)            136-145             138              
  S. K+ (mEq/L)             3.5-4.5             4.45             
  S. uric acid (mg/dL)      2.6-6.0             3.0              
  S. calcium (mg/dL)        8.0-10.8            5.4       6.1    7.3
  Ionized Ca^2+^ (mmol/L)   1.15-1.33           0.58      0.77   1.04
  Phosphorus (mg/dL)        2.8-4.0             5.0              4.2
  Magnesium (mg/dl)         1.7-2.7             1.03             2.2
  PTH (pg/mL)               12-68               0.70             
  Vitamin D (ng/mL)         30-50               47               
  QTc (Bazett formula)      \<450 ms (female)   520              
  Procalcitonin             0.025-0.300         0.300            

Discussion {#sec1-3}
==========

The Global Initiative for Chronic Obstructive Lung Disease (GOLD), a project initiated by the National Heart, Lung, and Blood Institute (NHLBI) and the World Health Organization (WHO), defines COPD as follows\[[@ref5]\]-

"COPD is a common, preventable, and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases. The chronic airflow limitation that characterizes COPD is caused by a mixture of small airways disease (e.g. obstructive bronchiolitis) and parenchymal destruction (emphysema), the relative contributions of which vary from person to person. Chronic inflammation causes structural changes, small airways narrowing, and destruction of lung parenchyma. A loss of small airways may contribute to airflow limitation and mucociliary dysfunction, a characteristic feature of the disease."

On some rare occasions, the cause of exacerbation may remain unknown. Hypocalcemia is one of those causes which may not be thought initially if a strong suspicion is not kept. The typical symptoms of hypocalcemia are paresthesias in the peri-oral and extremities along with fatigue, anxiety and tetany. In extreme cases, bronchospasm and laryngospasm with wheeze and stridor may occur, as a result of neuromuscular irritability.\[[@ref6]\]

In our case also, she presented with acute exacerbation along with typical symptoms and characteristics ECG changes of hypocalcemia. He was initially given standard treatment (inhaled bronchodilator and steroid) but without significant improvement. Subsequently, she was given calcium infusion and her symptoms dramatically improved. The cause of hypocalcemia was found to be due to hypomagnesemia and low PTH. A low magnesium level reduces the PTH secretion and as well as end-organ receptor sensitivity.\[[@ref7]\] In a recently conducted study it has been found that In elderly patients with acute exacerbation of COPD, hypocalcemia may be related to the disease progression, hospitalization and infection rate.

Since COPD is so common in our society because of the high burden of a smoker, a primary care physician should be able to treat those acute events. However, this case has taught us that if a smart suspicion is not kept on all the parameters related to a patient, a physician can miss the easily correctable factors.

Conclusion {#sec1-4}
==========

COPD is a very prevalent disease in developing countries like India where smoking and environmental pollutants exist almost everywhere. Both family medicine, as well as internist, encounter a lot of patients with acute exacerbation. Hence, it is important for the primary care physician to be able to suspect those rare causes of an acute exacerbation if initial routine care doesn\'t seem to be effective. Being vigilant to those correctable causes like electrolyte imbalance can help the family physicians in better patient management.
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